Jérôme PelletierUniversité de Montréal | UdeM · Faculty of Veterinary Medicine
Jérôme Pelletier
Doctor of Veterinary Medicine
About
11
Publications
2,519
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
126
Citations
Citations since 2017
Introduction
Doctor of veterinary medecine and Ph D candidate in epidemiology at Faculté de Médecine Vétérinaire of Université de Montréal in Saint-Hyacinthe. I am currently working on Lyme disease prevention and control. My project aims to reduce Lyme disease risk in the environment by targeting Borrelia burgdorferi reservoirs.
Publications
Publications (11)
Objective
In 2021, a first outbreak of anaplasmosis occurred in animals and humans in southern Québec, with 64% of confirmed human cases located in Bromont municipality. Ixodes scapularis ticks and Peromyscus mouse ear biopsies collected in Bromont from 2019 to 2021 were analyzed for Anaplasma phagocytophilum (Ap) with the objective of determining...
The development of interventions that reduce Lyme disease incidence remains a challenge. Reservoir-targeted approaches aiming to reduce tick densities or tick infection prevalence with Borrelia burgdorferi have emerged as promising ways to reduce the density of infected ticks. Acaricides of the isoxazoline family offer high potential for reducing i...
Background: Lyme disease (LD) is an increasing public health threat in temperate zones of the northern hemisphere, yet relatively few methods exist for reducing LD risk in endemic areas. Disrupting the LD transmission cycle in nature is a promising avenue for risk reduction. This experimental study evaluated the efficacy of fluralaner, a recent ora...
Lyme disease (LD) represent an important threat for public heath worldwide and an emerging threat in Canada. Yet, few methods exist to reduce the LD transmission risk in endemic area. A promising avenue to achieve risk reduction is the disruption of LD transmission cycle in nature by treating the small rodent reservoirs of its etiological agent, th...
Context. Lyme disease (LD) is an important North American tick-born disease that is emerging in Canada. In parallel, new effective drugs against ticks like fluralaner, an Isoxazoline, appear on the market.
Objective. Reduce LD transmission risk to humans by treating ecological reservoirs of its etiological agent with fluralaner.
Methodology. Evalua...
Introduction:
Ketamine is a common recreational drug. Severe lower urinary tract symptoms associated with its consumption have been reported, but little is known about the involved mechanisms. The effect of ketamine, which is excreted in urine, was evaluated by its application on an in vitro three-dimensional human tissue-engineered bladder model...
Aggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimer's disease. The causes and consequences of tau hyperphosphorylation are routinely investigated in laboratory animals. Mice are the models of choice as they are easily amenable to transgenic technology; consequently, their tau p...
Projects
Project (1)
Lyme disease, caused by the bacteria Borrelia burgdorferi, and its vector, the black-legged tick Ixodes scapularis, is currently emerging in southern Quebec. One approach to reduce the risk of Lyme disease is to treat the rodent reservoirs of the disease in nature to control ticks and thus interrupt local endemic cycle of the disease. My Ph D project focuses on evaluating a new approach for treating wild rodents with potential applications for the control of tick populations in periurban environements.
